About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a commercial-stage rare disease company combining science, data, and patient needs to create transformational therapies for diseases with ...

Rare conditions present their own difficulties in terms of medicines adherence, but HCPs, pharma and patients can pool their experience to develop effective, tailored support. It is well ...

Native Vote 2024. Mesothelioma is a rare cancer caused by asbestos exposure, with military personnel being among the groups ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical-stage, specialty pharmaceutical company focused on developing and commercializing novel treatments for rare and orphan ...

Interim data from ENERGY 1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for fourth quarter of 2024 –- Topline data ...

Pancreatic cancer is recognized as one of the deadliest forms of cancer, yet a significant number of Americans remain misinformed about its risks and ...

Cooper Vision describes keratoconus as 'a condition where the cornea protrudes outward like a cone'.

Jefferies and Leerink Partners are acting as the joint book-running managers for the offering and Wedbush PacGrow is acting as co-manager.

Russian glide bombs, drones and a ballistic missile smashed into cities in southern and eastern Ukraine on Monday, officials ...

Do you want a new shrub for your garden that says "classy and exclusive?" Cocoplum shrub is such a plant; today we will ...

A 27-year-old woman faces a constant reminder of her mortality due to a rare genetic heart condition that could result in her ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company focused on novel treatments for rare and orphan diseases ... a ...